AAM
IMMU

Advisors Asset Management’s Immunomedics Inc IMMU Stock Holding History

Advisors Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,820
Closed -$495K – 1570
2020
Q3 		$495K Buy
5,820
+2,696
+86% +$136K 0.01% 924
2020
Q2 		$111K Buy
+3,124
New +$91.3K ﹤0.01% 1283

Advisors Asset Management's IMMU Position: Q4 2020 in Review

Advisors Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 5,820 shares — an estimated $495K sold.

Advisors Asset Management first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $495K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Advisors Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Advisors Asset Management sold 5,820 Immunomedics Inc shares in Q4 2020, an estimated $495K.
  • Advisors Asset Management first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Advisors Asset Management's Immunomedics Inc position peaked at $495K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Advisors Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.